Treating early choroidal neovascularisation with pegaptanib sodium in patients with neovascular age-related macular degeneration: Findings of the PERSPECTIVES study

Chakravarthy U., Staurenghi G., Kwok K., Tressler C.S., Buggage R.

2012
British Journal of Ophthalmology

View publication

Therapeutic Area

Back of the eye (BOTE)
Categories

Clinical development

Affiliations

Central Angiographic Resource Facility, Queens University of Belfast, Belfast, United Kingdom; Department of Clinical Science Luigi Sacco, Eye Clinic, University of Milan, Milano, Italy; Pfizer Inc., New York, NY, United States; Novagali Pharma, Evry, France

Related Publications

Economic evaluation, resource utilisation, and associated economic burden of myopia management: a systematic literature review

de Milliano T. WL, Shi-van Wielink K., Ernst F., Mulkalapalli N., Pagidigummula R., Lymperopoulou C.

Efficacy and Safety of Low-Concentration Atropine in Slowing Myopia Progression in Children in Japan: The Randomized, Double-Blind Phase II/III ORANGE Study

Ohno-Matsui K., Igarashi-Yokoi T., Migita Y., Yamakawa Y, on behalf of the ORANGE study investigators

Awareness of Myopia Associated Complications and Perspectives on Myopia Management Among Parents of Children with Myopia in France and the UK

Hafizi R., Deferne N., Paudel N., Angerer A., Hsieh H.-T.

View all Back of the eye (BOTE) publications

Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022